Pronađeno: 1-9 / 9 radova

Autori: Bril Vera

>> Filter: Samo Article i Review

Naslov Long-term safety and tolerability of hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: Results from the ADVANCE-CIDP 3 trial (Article; Early Access)
Autori Hadden Robert DM  Andersen Henning  Bril Vera  Basta Ivana Z  Rejdak Konrad  Duff Kim  Greco Erin  Hasan Shabbir  Anderson Smits Colin  Ay Hakan 
Info JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, (2024), vol. br. , str. -
Projekat Takeda Development Center Americas, Inc.; Takeda Development Center Americas, Inc. - Takeda Pharmaceuticals International AG
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati:
Naslov Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% for CIDP: Final Results from a Long-Term Safety and Tolerability Study (Meeting Abstract)
Autori Hadden Robert DM  Andersen Henning  Bril Vera  Basta Ivana Z  Rejdak Konrad  Duff Kim  Greco Erin  Hasan Shabbir  Anderson Smits Colin  Ay Hakan 
Info JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, (2024), vol. 29 br. , Suppl. 3, str. S78-S79
Ispravka ISI/Web of Science   Elečas   Rang časopisa  
Naslov Long-term safety, tolerability, and efficacy of efgartigimod in patients with generalized myasthenia gravis: Concluding analyses from the ADAPT plus study (Meeting Abstract)
Autori Bril Vera  ...  Peric Stojan Z  ...  (broj koautora 17) 
Info JOURNAL OF THE NEUROLOGICAL SCIENCES, (2023), vol. 455 br. , Suppl. S, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa  
Naslov Facilitated subcutaneous immunoglobulin 10% for CIDP: interim results from a long-term safety and tolerability study (Meeting Abstract)
Autori Hadden R  Andersen H  Bril Vera  Basta Ivana Z  Rejdak Konrad  Djordjevic Goran D  Greco E  Hasan S  French J  Yel L  Ay H 
Info EUROPEAN JOURNAL OF NEUROLOGY, (2023), vol. 30 br. , Suppl. 1, str. 286-286
Projekat Takeda Development Center Americas, Inc./Takeda Pharmaceuticals International AG
Ispravka ISI/Web of Science   Elečas   Rang časopisa  
Naslov Long-Term Assessment of Efgartigimod in Patients with Generalised Myasthenia Gravis: Adapt Plus Study Interim Results (Meeting Abstract)
Autori Jacob Saiju  Howard James F Jr  Bril Vera  Peric Stojan Z  De Bleecker Jan L  T'joen Caroline  Travers Jackalyne  Utsugisawa Kimiaki  Verschuuren Jan  Mantegazza Renato 
Info JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, (2022), vol. 93 br. 9, str. -
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Efficacy, Safety, and Tolerability of Efgartigimod in Acetylcholine Receptor Autoantibody Seronegative Patients with Generalized Myasthenia Gravis: Integrated Interim Analysis of the Adapt and Adapt plus Studies (Meeting Abstract)
Autori Howard James F Jr  Bril Vera  Tuan Vu  Karam Chafic  Peric Stojan Z  De Bleecker Jan L  Murai Hiroyuki  Pasnoor Mamatha  Sacca Francesco  Meisel Andreas  Guglietta Antonio  T'joen Caroline  Utsugisawa Kimiaki  Verschuuren Jan  Mantegazza Renato 
Info MUSCLE & NERVE, (2022), vol. 65 br. , Suppl. 1, str. S13-S14
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Long-Term Safety, Tolerability, and Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Interim Results of the Adapt plus Study (Meeting Abstract)
Autori Howard James F Jr  Bril Vera  Tuan Vu  Karam Chafic  Peric Stojan Z  De Bleecker Jan L  Murai Hiroyuki  Meisel Andreas  Beydoun Said  Pasnoor Mamatha  Guglietta Antonio  T'joen Caroline  Utsugisawa Kimiaki  Verschuuren Jan  Mantegazza Renato 
Info MUSCLE & NERVE, (2022), vol. 65 br. , Suppl. 1, str. S9-S10
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Efficacy, Safety, and Tolerability of Efgartigimod in Patients With Generalized Myasthenia Gravis: Analysis of the Phase 3 ADAPT Study (Meeting Abstract)
Autori Howard James  Bril Vera  Vu Tuan  Karam Chafic  Peric Stojan Z  Murai Hiroyuki  Guglietta Antonio  Ulrichts Peter  Vangeneugden Tony  Utsugisawa Kimiaki  Verschuuren Jan JGM  Mantegazza Renato 
Info NEUROLOGY, (2021), vol. 96 br. 15, Suppl. S, str. -
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Analysis of Efgartigimod Efficacy Across Patient Populations and Myasthenia Gravis Specific Scales: Results of the Phase 3 ADAPT Study (Meeting Abstract)
Autori Bril Vera  ...  Peric Stojan Z  ...  (broj koautora 16) 
Info ANNALS OF NEUROLOGY, (2021), vol. 90 br. , Suppl. 27, str. S28-S28
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX